Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)

Completed · Phase 3

Conditions studied: Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma

In brief

The primary objective of this study is to assess the effect of treatment with bendamustine on cardiac repolarization as reflected by the rate-corrected QT interval by the Fridericia method (QTcF).

Key facts

Study ID
NCT01073163
Run by
Cephalon
People needed
54
Starts
2010-02-01
Expected to finish
2012-06-01
Last updated by the study team
2014-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.